Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACE | P12821 | 7/20 | 0.57 |
| ▸ | ACE2 | Q9BYF1 | 3/20 | 0.56 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.50 |
| ▸ | REN | P00797 | 1/20 | 0.49 |
| ▸ | GNAI3 | P08754 | 1/20 | 0.48 |
| ▸ | GNAO1 | P09471 | 1/20 | 0.48 |
| ▸ | GNAI1 | P63096 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19024815 | 1.00 | ACE (0.57) | ACEACE2L3MBTL1RENGNAI3 | |
| SCHEMBL10756784 | 1.00 | ACE (0.57) | ACEACE2L3MBTL1RENGNAI3 | |
| SCHEMBL15650301 | 1.00 | ACE (0.57) | ACEACE2L3MBTL1RENGNAI3 | |
| SCHEMBL5036114 | 1.00 | ACE (0.57) | ACEACE2L3MBTL1RENGNAI3 | |
| SCHEMBL5033212 | 1.00 | ACE (0.57) | ACEACE2L3MBTL1RENGNAI3 | |
| SCHEMBL15649718 | 1.00 | ACE (0.57) | ACEACE2L3MBTL1RENGNAI3 | |
| SCHEMBL317272 | 1.00 | ACE (0.57) | ACEACE2L3MBTL1RENGNAI3 | |
| SCHEMBL2635949 | 1.00 | ACE (0.57) | ACEACE2L3MBTL1RENGNAI3 | |
| SCHEMBL21853572 | 1.00 | ACE (0.57) | ACEACE2L3MBTL1RENGNAI3 | |
| SCHEMBL19024591 | 1.00 | ACE (0.57) | ACEACE2L3MBTL1RENGNAI3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 46 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115427007-A | Transparent shampoo block and preparation method thereof | 汉高股份有限及两合公司 | 2022-12-02 | — | — | CN | claimed |
| US-12559611-B2 | Hydrophobic alginic acid particle group and method for producing same | NISSHINBO HOLDINGS INC. (JP) | 2026-02-24 | — | — | US | disclosed |
| EP-4640751-A1 | MARINE BIODEGRADABLE POLYMER PARTICLE GROUPS AND PRODUCTION METHOD FOR SAME | Nisshinbo Holdings Inc. (JP) | 2025-10-29 | — | — | EP | disclosed |
| US-12441850-B2 | Amphiphilic alginic acid particle group and method for producing same | NISSHINBO HOLDINGS INC. (JP) | 2025-10-14 | — | — | US | disclosed |
| WO-2025069893-A1 | CROSSLINKED MARINE BIODEGRADABLE POLYMER COMPOUND COMPRISING DIFFERENT ANIONIC POLYMER COMPOUNDS, AND METHOD FOR PRODUCING SAME | 日清紡ホールディングス株式会社 | 2025-04-03 | — | — | WO | disclosed |
| US-20250034360-A1 | MARINE BIODEGRADATION PROMOTER HAVING TWO OR MORE MONOVALENT ORGANIC ANIONS, AND MARINE BIODEGRADABLE COMPOSITION | NISSHINBO HOLDINGS INC. (JP) | 2025-01-30 | — | — | US | disclosed |
| US-20250019492-A1 | MARINE BIODEGRADABLE POLYMER COMPOUND, MARINE BIODEGRADATION PROMOTER, AND MARINE BIODEGRADABLE RESIN COMPOSITION | NISSHINBO HOLDINGS INC. (JP) | 2025-01-16 | — | — | US | disclosed |
| US-20250011570-A1 | MARINE BIODEGRADATION PROMOTER HAVING HYDROCARBON GROUP, AND MARINE BIODEGRADABLE COMPOSITION | NISSHINBO HOLDINGS INC. (JP) | 2025-01-09 | — | — | US | disclosed |
| EP-4442728-A1 | MARINE BIODEGRADABLE POLYMER COMPOUND, MARINE BIODEGRADATION PROMOTER, AND MARINE BIODEGRADABLE RESIN COMPOSITION | Nisshinbo Holdings Inc. (JP) | 2024-10-09 | — | — | EP | disclosed |
| EP-4442748-A1 | MARINE BIODEGRADATION PROMOTER HAVING TWO OR MORE MONOVALENT ORGANIC ANIONS, AND MARINE BIODEGRADABLE COMPOSITION | Nisshinbo Holdings Inc. (JP) | 2024-10-09 | — | — | EP | disclosed |
| US-20190274954-A1 | Copositions in the form of an injectable aqueous solution comprising amylin, an amylin receptor agonist or an amylin analog and a co-polyamino acid | ADOCIA (FR) | 2019-09-12 | — | — | US | disclosed |
| US-20190275156-A1 | COMPOSITIONS SOUS FORME D'UNE SOLUTION AQUEUSE INJECTABLE COMPRENANT DU GLUCAGON HUMAIN ET UN CO-POLYAMINOACIDE | ADOCIA (FR) | 2019-09-12 | — | — | US | disclosed |
| US-20190275115-A1 | INJECTABLE SOLUTION AT PH 7 COMPRISING AT LEAST ONE BASAL INSULIN WHEREIN THE PI IS COMPRISED FORM 5.8 TO 8.5 AND A CO-POLYAMINO ACID BEARING CARBOXYLATE CHARGES AND HYDROPHOBIC RADICALS | ADOCIA (FR) | 2019-09-12 | — | — | US | disclosed |
| US-9782336-B2 | Moisturizer and cosmetic containing same | AJINOMOTO CO., INC. (JP) | 2017-10-10 | — | — | US | disclosed |
| EP-3192493-A1 | MOISTURIZER AND COSMETIC CONTAINING SAME | Ajinomoto Co., Inc. (JP) | 2017-07-19 | — | — | EP | disclosed |
| US-20170181947-A1 | MOISTURIZER AND COSMETIC CONTAINING SAME | AJINOMOTO CO., INC. (JP) | 2017-06-29 | — | — | US | disclosed |
| WO-2011141685-A2 | SYSTEMIC NASAL COMPOSITIONS COMPRISING COCOYL PROLINE OR AT LEAST ONE OF THE CONSTITUENTS THEREOF | PHYSICA PHARMA SAS (FR) | 2011-11-17 | — | — | WO | disclosed |
| US-4837026-A | Transdermal and systemic preparation and method | THERAPEUTIC PATCH RESEARCH N.V. | 1989-06-06 | — | — | US | disclosed |
| EP-0240554-A1 | TRANSDERMAL AND SYSTEMIC PREPARATION AND METHOD | RAJADHYAKSHA, Vithal J. (US) | 1987-10-14 | — | — | EP | disclosed |
| WO-1987001935-A1 | TRANSDERMAL AND SYSTEMIC PREPARATION AND METHOD | RAJADHYAKSHA VITHAL J | 1987-04-09 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170181947-A1 | MOISTURIZER AND COSMETIC CONTAINING SAME | PPT1, ACOX1, ALDH18A1 | ACE 2920/4885ACE2 2772/4885L3MBTL1 4184/4885 |
| US-20190275156-A1 | COMPOSITIONS SOUS FORME D'UNE SOLUTION AQUEUSE INJECTABLE COMPRENANT DU GLUCAGON HUMAIN ET UN CO-POLYAMINOACIDE | GCG, GLP1R, GHSR | ACE 2067/4885ACE2 2446/4885L3MBTL1 3243/4885 |
| US-20190274954-A1 | Copositions in the form of an injectable aqueous solution comprising amylin, an amylin receptor agonist or an amylin analog and a co-polyamino acid | IAPP, GLP1R, INSR | ACE 746/4885ACE2 1073/4885L3MBTL1 4379/4885 |
| US-12559611-B2 | Hydrophobic alginic acid particle group and method for producing same | ALG3, ALG1, HACD3 | ACE 4321/4885ACE2 2004/4885L3MBTL1 2725/4885 |
| US-20190275115-A1 | INJECTABLE SOLUTION AT PH 7 COMPRISING AT LEAST ONE BASAL INSULIN WHEREIN THE PI IS COMPRISED FORM 5.8 TO 8.5 AND A CO-POLYAMINO ACID BEARING CARBOXYLATE CHARGES AND HYDROPHOBIC RADICALS | IAPP, GCG, HBB | ACE 2119/4885ACE2 3240/4885L3MBTL1 2828/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.